Alexion Pharmaceuticals

ALXN-Q

NASDAQ:ALXN

115.14
3.07 (2.60%)
Alexion Pharmaceuticals Inc. is an American pharmaceutical company best known for its development of Soliris, a drug used to treat the rare disorders atypical hemolytic uremic syndrome and paroxysmal nocturnal hemoglobinuria.
More at Wikipedia

Analysis and Opinions about ALXN-Q

Signal
Opinion
Expert
COMMENT
COMMENT
May 23, 2017

Biotech can be a big win or a big loss. A lot of companies have binary outcomes, their product either works or it doesn’t. This company recently had a significant disappointment. US investors are not very sympathetic to these types of situations. They shoot first and ask questions later. If you want to own biotech, he would suggest you own a tech with lots of different products, or buy an ETF that gives you a basket. This one is a broken stock.

Show full opinionHide full opinion

Biotech can be a big win or a big loss. A lot of companies have binary outcomes, their product either works or it doesn’t. This company recently had a significant disappointment. US investors are not very sympathetic to these types of situations. They shoot first and ask questions later. If you want to own biotech, he would suggest you own a tech with lots of different products, or buy an ETF that gives you a basket. This one is a broken stock.

PAST TOP PICK
PAST TOP PICK
February 20, 2008

(Top Short Mar 9/07. Up 202%.) News on this was positive so he exited his short position.

Show full opinionHide full opinion

(Top Short Mar 9/07. Up 202%.) News on this was positive so he exited his short position.

PAST TOP PICK
PAST TOP PICK
May 23, 2007

(Top Short March 9/07.) You would have entered at about $37 and with your trailing stop you would have been out in a few days and probably would've broken even including your commissions. Had expected bad news, but they had some positive news.

Show full opinionHide full opinion

(Top Short March 9/07.) You would have entered at about $37 and with your trailing stop you would have been out in a few days and probably would've broken even including your commissions. Had expected bad news, but they had some positive news.

TOP PICK
TOP PICK
March 9, 2007
Top Short There's a small problem with this stock. Around March 20 they are going to be releasing some news that might have major influence on the stock. Had a very long base around $34 and thinks this is where the stock is heading. Volumes are not large. Use a $1 trailing stop.
Show full opinionHide full opinion
Top Short There's a small problem with this stock. Around March 20 they are going to be releasing some news that might have major influence on the stock. Had a very long base around $34 and thinks this is where the stock is heading. Volumes are not large. Use a $1 trailing stop.
Showing 1 to 4 of 4 entries
  • «
  • 1
  • »

Alexion Pharmaceuticals(ALXN-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Alexion Pharmaceuticals is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Alexion Pharmaceuticals(ALXN-Q) Frequently Asked Questions

What is Alexion Pharmaceuticals stock symbol?

Alexion Pharmaceuticals is a American stock, trading under the symbol ALXN-Q on the NASDAQ (ALXN). It is usually referred to as NASDAQ:ALXN or ALXN-Q

Is Alexion Pharmaceuticals a buy or a sell?

In the last year, there was no coverage of Alexion Pharmaceuticals published on Stockchase.

Is Alexion Pharmaceuticals a good investment or a top pick?

Alexion Pharmaceuticals was recommended as a Top Pick by David Burrows on 2017-05-23. Read the latest stock experts ratings for Alexion Pharmaceuticals.

Why is Alexion Pharmaceuticals stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Alexion Pharmaceuticals worth watching?

In the last year, there was no coverage of Alexion Pharmaceuticals published on Stockchase.

What is Alexion Pharmaceuticals stock price?

On 2020-10-30, Alexion Pharmaceuticals (ALXN-Q) stock closed at a price of $115.14.